Skip to Content

  • Search

View Additional Section Content

Kendle/AMH Protocol: Administration, Double-Blind, Parallel-Group, Phase 2 Dose Finding Study to Assess the Efficacy, Tolerability and Safety of TRG(Intranasal Granisetron) in Patients with Chemotherapy Induced Nausea and Vomiting(CINV)Associated with the Administration of Highly Emetogenic Chemotherapy

Clinical Trial Categories

  • Ovarian Cancer
Contact
Hanjani Institute for Gynecologic Oncology at 215-885-0220

Location

  • Hanjani Institute for Gynecologic Oncology
    The Rosenfeld Cancer Center
    1200 Old York Rd, AMH - 1 Widener
    Abington, PA 19001
    Office: 215-885-0220
    Fax: 215-576-0740

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details